BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3128617)

  • 1. [A combined chemo-endocrine therapy of advanced renal cell carcinoma].
    Wada T; Yasutomi M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2294-8. PubMed ID: 3128617
    [No Abstract]   [Full Text] [Related]  

  • 2. [A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma].
    Wada T; Morikawa E; Yasutomi M; Takagi H; Aizawa M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1652-6. PubMed ID: 2230447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma.
    Wada T; Houjou T; Kubo R; Yasutomi M; Kurita T
    Anticancer Res; 1993; 13(6B):2465-7. PubMed ID: 8135483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma.
    Wada T; Nishiyama K; Maeda M; Hara S; Tanaka N; Yasutomi M; Kurita T
    Anticancer Res; 1995; 15(4):1581-4. PubMed ID: 7654050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of UFT in far-advanced renal cell carcinoma].
    Matsuyama H; Yamamoto N; Sakatoku J; Hara Y; Sacho T; Yasui H; Ichikawa T; Koshido Y; Hayasida S; Nagata K
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):527-30. PubMed ID: 3126711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
    Masuda F; Nakada J; Kondo I; Furuta N
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2143-6. PubMed ID: 1888185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
    Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y
    Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of UFT in advanced renal cell cancer].
    Koseki K; Akaza H; Kishi H; Umeda T; Isurugi K; Niijima T
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2061-4. PubMed ID: 3931562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effect of UFT in advanced renal cell carcinoma].
    Hoshino M; Inoue K; Higaki M; Imamura K
    Hinyokika Kiyo; 1988 Mar; 34(3):538-40. PubMed ID: 3133935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
    Sugawara T; Sakuramoto T; Fukushima S
    Hinyokika Kiyo; 1987 Aug; 33(8):1232-5. PubMed ID: 3122543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in chemotherapy for renal cell carcinoma.
    Huben RP
    Semin Urol; 1992 Feb; 10(1):16-22. PubMed ID: 1565899
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of UFT for the treatment of renal cell carcinoma.
    Masuda F; Mori Y; Nakada J
    Prog Clin Biol Res; 1989; 303():707-9. PubMed ID: 2506559
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach].
    Kitaoka H
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2453-60. PubMed ID: 6418074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of UFT in renal cell carcinoma].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):325-30. PubMed ID: 3918508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ACFT therapy using adriamycin, cyclophosphamide, tegafur and tamoxifen against progressive breast cancer].
    Watanabe Y; Tamura M; Meguro F
    Gan To Kagaku Ryoho; 1988 May; 15(5):1711-4. PubMed ID: 3130805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T; Washizuka M; Kihara K; Takahashi T; Sakata Y; Tai K; Nagayama T; Okada K; Kusuyama H; Ishii Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):40-6. PubMed ID: 3611890
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
    Niijima T; Aso Y; Akaza H; Kameyama S; Koiso K; Kawabe K; Kawamura T; Isurugi K; Yokoyama M; Shoji F
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):109-14. PubMed ID: 3122664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer].
    Imajo K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Ozeki H; Nagamine D; Shinagawa K; Fukutani H
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):121-6. PubMed ID: 3122665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.